Work

Changes in Brain Activity with Antisense Oligonucleotide RG6042 Treatment in Early Manifest Huntington’s Disease (HD) (4003)

Year: 2020

Type: article

Source: Neurology

DOI: 10.1212/wnl.94.15_supplement.4003

Authors: David J. Hawellek, Pilar Garces, Amir H. Meghdadi, Shani Waninger, Anne Smith, Marianne Manchester, Scott A. Schobel, Joerg F. Hipp

Institutions: F. Hoffmann-La Roche AG, Advanced Brain Monitoring (United States), Ionis Pharmaceuticals (United States)

Language: English

Topic: Genetic Neurodegenerative Diseases

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3130284171

FWCI:

Cites:

Cited by:

Related to: 10